Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN951020 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Cannabinoid Receptor 2 (CNR2) (C-Term), (AA 331-360) antibody
- Antibody type
- Polyclonal
- Antigen
- KLH conjugated synthetic peptide between 331-360 amino acids from the C-terminal region of human CB2
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term,AA 331-360
- Vial size
- 0.4 mL
- Concentration
- 0.25 mg/mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Expression of cannabinoid receptors in human kidney.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle.
Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas.
Association study of 182 candidate genes in anorexia nervosa.
Larrinaga G, Varona A, Pérez I, Sanz B, Ugalde A, Cándenas ML, Pinto FM, Gil J, López JI
Histology and histopathology 2010 Sep;25(9):1133-8
Histology and histopathology 2010 Sep;25(9):1133-8
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle.
Taylor AH, Abbas MS, Habiba MA, Konje JC
Histochemistry and cell biology 2010 May;133(5):557-65
Histochemistry and cell biology 2010 May;133(5):557-65
Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas.
De Jesús ML, Hostalot C, Garibi JM, Sallés J, Meana JJ, Callado LF
Neurochemistry international 2010 May-Jun;56(6-7):829-33
Neurochemistry international 2010 May-Jun;56(6-7):829-33
Association study of 182 candidate genes in anorexia nervosa.
Pinheiro AP, Bulik CM, Thornton LM, Sullivan PF, Root TL, Bloss CS, Berrettini WH, Schork NJ, Kaye WH, Bergen AW, Magistretti P, Brandt H, Crawford S, Crow S, Fichter MM, Goldman D, Halmi KA, Johnson C, Kaplan AS, Keel PK, Klump KL, La Via M, Mitchell JE, Strober M, Rotondo A, Treasure J, Woodside DB
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2010 Jul;153B(5):1070-80
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2010 Jul;153B(5):1070-80
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- CB2 Antibody (C-term) (Cat. #AP50740PU-N) western blot analysis in Jurkat cell line lysates (35μg/lane).This demonstrates the CB2 antibody detected the CB2 protein (arrow).
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- CB2 antibody (C-term) (Cat. #AP50740PU-N) immunohistochemistry analysis in formalin fixed and paraffin embedded human skin carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the CB2 antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- CB2 Antibody (C-term) (Cat. #AP50740PU-N) flow cytometric analysis of Jurkat cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
